MA21953A1 - Composition de faible dose d'inhibiteur de plaquette/d'anticoagulant buccal . - Google Patents

Composition de faible dose d'inhibiteur de plaquette/d'anticoagulant buccal .

Info

Publication number
MA21953A1
MA21953A1 MA22225A MA22225A MA21953A1 MA 21953 A1 MA21953 A1 MA 21953A1 MA 22225 A MA22225 A MA 22225A MA 22225 A MA22225 A MA 22225A MA 21953 A1 MA21953 A1 MA 21953A1
Authority
MA
Morocco
Prior art keywords
composition
oral anticoagulant
low dose
inhibitor
plate
Prior art date
Application number
MA22225A
Other languages
English (en)
Inventor
J Addicks W
H Slatko G
A Mollica J
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of MA21953A1 publication Critical patent/MA21953A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
MA22225A 1989-09-18 1990-09-17 Composition de faible dose d'inhibiteur de plaquette/d'anticoagulant buccal . MA21953A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/408,394 US5041430A (en) 1989-09-18 1989-09-18 Oral anticoagulant/platelet inhibitor low dose formulation

Publications (1)

Publication Number Publication Date
MA21953A1 true MA21953A1 (fr) 1991-04-01

Family

ID=23616120

Family Applications (1)

Application Number Title Priority Date Filing Date
MA22225A MA21953A1 (fr) 1989-09-18 1990-09-17 Composition de faible dose d'inhibiteur de plaquette/d'anticoagulant buccal .

Country Status (22)

Country Link
US (1) US5041430A (fr)
EP (1) EP0493408B1 (fr)
JP (1) JPH05501109A (fr)
KR (1) KR950008307B1 (fr)
AT (1) ATE137972T1 (fr)
AU (1) AU635881B2 (fr)
CA (1) CA2065347A1 (fr)
CZ (1) CZ454090A3 (fr)
DE (1) DE69027036D1 (fr)
FI (1) FI921134A (fr)
GR (1) GR1001131B (fr)
HU (1) HUT62488A (fr)
IE (1) IE903356A1 (fr)
IL (1) IL95721A (fr)
LV (1) LV10050B (fr)
MA (1) MA21953A1 (fr)
MX (1) MX173727B (fr)
NO (1) NO920946D0 (fr)
NZ (1) NZ235337A (fr)
PT (1) PT95343B (fr)
WO (1) WO1991004031A1 (fr)
ZA (1) ZA907431B (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5780303A (en) * 1990-04-06 1998-07-14 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US6521594B1 (en) 1990-04-06 2003-02-18 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5612311A (en) 1990-04-06 1997-03-18 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5672585A (en) * 1990-04-06 1997-09-30 La Jolla Cancer Research Foundation Method and composition for treating thrombosis
US5635477A (en) * 1991-09-30 1997-06-03 The Dupont Merck Pharmaceutical Company Cyclic compounds useful as inhibitors of platelet glycoprotein IIB/IIIA
CA2100836C (fr) * 1993-07-19 1998-02-03 Bernard Charles Sherman Composition pharmaceutique
AU5787996A (en) * 1995-04-19 1996-11-07 Lipoprotein Technologies, Inc. Compositions, kits, and methods for administration of antilipemic and anti-platelet aggregation drugs
US8022095B2 (en) * 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
US6121249A (en) * 1998-07-01 2000-09-19 Donald L. Weissman Treatment and prevention of cardiovascular diseases with help of aspirin, antioxidants, niacin, and certain B vitamins
IT1312088B1 (it) * 1999-04-21 2002-04-04 Altergon Sa Cerotto per uso topico contenente eparina e diclofenac.
US8173164B2 (en) * 1999-06-17 2012-05-08 Gruenenthal Gmbh Oral administration forms for administering a fixed tramadol and diclofenac combination
AU2002226986A1 (en) * 2000-12-01 2002-06-11 Rheologics, Inc. In vivo delivery methods and compositions
WO2002079778A2 (fr) * 2001-03-28 2002-10-10 Rheologics, Inc. Methodes d'administration in vivo et compositions
AU2003220022A1 (en) * 2002-03-01 2003-09-16 Trustees Of Dartmouth College Compositions and methods for preventing sporadic neoplasia in colon
US20050215625A9 (en) * 2003-01-08 2005-09-29 Nesselroad James M Iii Combination therapy for anticoagulation
CZ20032854A3 (cs) * 2003-10-17 2005-05-18 Pliva - Lachema A.S. Způsob přípravy dávkových jednotek pevné lékové formy obsahujících jako účinnou látku sodnou sůl warfarinu
AU2004285436C1 (en) * 2003-10-20 2009-07-16 Teva Pharmaceutical Industries Ltd. Composition and dosage form for sustained effect of levodopa
SI21637A (sl) * 2003-12-23 2005-06-30 LEK farmacevtska dru�ba d.d. Farmacevtska oblika z nadzorovanim sproščanjem
US20060003000A1 (en) * 2004-07-01 2006-01-05 Lawrence Solomon Adhesively bonded dosage form
ES2385832T3 (es) * 2004-05-21 2012-08-01 Accu-Break Technologies, Inc. Comprimidos farmacéuticos que presentan un segmento relativamente inactivo
US7838031B2 (en) * 2004-05-21 2010-11-23 Lawrence Solomon Method of administering a partial dose using a segmented pharmaceutical tablet
US8758814B2 (en) 2004-10-08 2014-06-24 Mcneil-Ppc, Inc. Chewable enteric coated aspirin tablets
US8057820B2 (en) * 2004-10-08 2011-11-15 Mcneil-Ppc, Inc. Enteric coated aspirin granules comingled with binder
JP4613590B2 (ja) 2004-11-16 2011-01-19 セイコーエプソン株式会社 実装基板及び電子機器
WO2008082542A1 (fr) * 2006-12-19 2008-07-10 Institute For Therapeutic Research, Inc. Combinaison de vitamine k et d'un antagoniste de vitamine k, tel que l'isomère r de la warfarine, la phenprocoumone ou l'isomère r de la phenprocoumone, comme traitement anticoagulant
WO2008156691A1 (fr) * 2007-06-19 2008-12-24 Duke University Anticoagulants en tant qu'agents anti-salissures
DE102008014237A1 (de) * 2008-03-14 2009-09-17 J. Rettenmaier & Söhne Gmbh + Co. Kg Direktverpressbares Tablettierhilfsmittel
JP5529404B2 (ja) * 2008-09-05 2014-06-25 東和薬品株式会社 アスピリン腸溶錠
CA2816957A1 (fr) * 2010-11-07 2012-05-10 Targegen, Inc. Compositions et procedes de traitement de la myelofibrose
LV14606B (lv) 2011-05-17 2013-01-20 Tetra, Sia Jauns XII faktora inhibitors
CZ2012435A3 (cs) * 2012-06-27 2013-11-13 Veterinární a farmaceutická univerzita Brno, Farmaceutická fakulta Zpusob prípravy pevné lékové formy se sodnou solí warfarinu ve forme klathrátu izopropanolu
JP6304751B2 (ja) * 2014-03-24 2018-04-04 日新製薬株式会社 ワルファリン含有固形製剤及びその製造方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2265273A1 (en) * 1974-03-29 1975-10-24 Zootherap Laboratoires Anticoagulant-contg. rodenticidal compsn. - contg. (acetyl) salicyclic acid or salt as synergist
LU77353A1 (fr) * 1977-05-16 1979-01-19
GB2038625B (en) * 1978-12-29 1983-01-12 Parcor Therapeutic composition having an antithrombotic and antiblood-platelet-aggregating activity
EP0001503B1 (fr) * 1977-10-08 1981-01-07 Beecham Group Plc Compositions à effet antithrombotique contenant des benzisothiazolones
SU1050708A1 (ru) * 1981-04-27 1983-10-30 Горьковский государственный медицинский институт им.С.М.Кирова Способ лечени гиперкоагул ции при коронарном атеросклерозе
US4444777A (en) * 1981-07-30 1984-04-24 Bristol-Myers Company Pharmaceutical compositions of anagrelide and sulfinpyrazone
DE3576119D1 (de) * 1984-07-21 1990-04-05 Hoechst Ag Kombinationspraeparat aus pyrimido-pyrimidinen und o-acetylsalicylsaeure bzw. deren pharmakologisch vertraeglichen salzen und dessen verwendung.

Also Published As

Publication number Publication date
IE903356A1 (en) 1991-04-10
EP0493408A4 (en) 1992-10-07
ATE137972T1 (de) 1996-06-15
GR1001131B (el) 1993-04-28
IL95721A0 (en) 1991-06-30
LV10050A (lv) 1994-05-10
AU6330690A (en) 1991-04-18
ZA907431B (en) 1992-05-27
CZ454090A3 (en) 1996-11-13
FI921134A0 (fi) 1992-03-17
PT95343A (pt) 1991-08-14
KR950008307B1 (ko) 1995-07-27
PT95343B (pt) 1998-06-30
US5041430A (en) 1991-08-20
MX173727B (es) 1994-03-24
HUT62488A (en) 1993-05-28
LV10050B (en) 1995-02-20
DE69027036D1 (de) 1996-06-20
EP0493408B1 (fr) 1996-05-15
FI921134A (fi) 1992-03-17
JPH05501109A (ja) 1993-03-04
NO920946L (no) 1992-03-11
GR900100702A (en) 1992-01-20
CA2065347A1 (fr) 1991-03-19
NO920946D0 (no) 1992-03-11
WO1991004031A1 (fr) 1991-04-04
IL95721A (en) 1995-07-31
KR920703046A (ko) 1992-12-17
EP0493408A1 (fr) 1992-07-08
AU635881B2 (en) 1993-04-01
NZ235337A (en) 1993-05-26

Similar Documents

Publication Publication Date Title
MA21953A1 (fr) Composition de faible dose d'inhibiteur de plaquette/d'anticoagulant buccal .
MX9205432A (es) Compuestos inhibidores de la biosintesis de leucotrienos y composicion farmaceutica que los contiene.
CO4950529A1 (es) Dihidropirimidinas y productos que las contienen
CA2206837A1 (fr) Utilisation de sels de strontium pour l'obtention de compositions pharmaceutiques destinees au traitement de l'arthrose
FI922364A0 (fi) Farmaceutiska kompositioner.
NO302366B1 (no) 4-merkaptoacetylamino-£2|benzazepinon(3)-derivater, og farmasöytisk preparat
DE69633680D1 (de) Behandlung von zns-wirkungen des hiv mit vx-478, allein oder kombiniert mit azt oder 3tc
IT8323205A0 (it) Composizioni farmaceutiche adattivita' antiinfiammatoria e/o analgesica, non ulcerogene.
AR240014A1 (es) Composicon oral inhibidora de placas dentales.
DE69006094D1 (de) Pharmazeutische Zusammensetzungen.
NO895311L (no) Antibakterielt plakk- og tannsteinmotvirkende oralt preparat.
DE69012702D1 (de) Dentalzusammensetzung.
BR9407743A (pt) Composiçao oral de peróxido de cálcio-bicarbonato
ES2177024T3 (es) Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer.
DE58902899D1 (de) 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer.
MX171542B (es) Composiciones farmaceuticas que contienen deoxirribonucleosidos para cicatrizacion de heridas
FR2707455B1 (fr) Empêchement de la reproduction des insectes xylophages, moyens pour le traitement préventif du matériau bois mis en Óoeuvre.
ES556806A0 (es) Un procedimiento para la preparacion de una composicion preventiva de la elastosis.
DE69003003D1 (de) Pharmazeutische Zusammensetzung.
ITRM920498A1 (it) Composizione per l'ignifugazione delle materie polimere.
AR240016A1 (es) Procedimiento de preparacion de una composicion para el tratamiento de flebectasias.
KR920700037A (ko) 치료에 유용한 혈소판 항-응집 효과를 갖는 조성물
ATE82855T1 (de) 2',3'-dideoxypurinnucleosid/purinnucleosidphosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer.
NO893069D0 (no) Fremgangsmaate for fremstilling av arbeidsstykker av ferritisk staal.
NO913299D0 (no) Fremgangsmaate for fremstilling av supraledende metalloxydsammensetninger.